Cryoport, Inc. CYRX

Rank #1984 · Nasdaq · $0.9B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

37.2

P/E

-8.8

P/B

1.57

ROE

-17.9%

Op. Margin

-59.6%

Debt Ratio

54%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -8.8x, P/B 1.57x. Ranks in the top 56% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -17.9%. Ranks in the top 84% of the universe.

Safety ★★★★☆

Good

Debt ratio 54%. Ranks in the top 25% of the universe.

Growth ★☆☆☆☆

Poor

Revenue decline of 28.9% year over year. Ranks in the top 94% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2011	–	$-0.0B	$-0.0B	$-0.0B	–	-556
2012	–	$-0.0B	$-0.0B	$0.0B	–	42
2014	–	$-0.0B	$-0.0B	$0.0B	–	102
2015	–	$-0.0B	$-0.0B	$-0.0B	–	-195
2016	–	$-0.0B	$-0.0B	$-0.0B	–	-131
2017	–	$-0.0B	$-0.0B	$0.0B	–	79
2018	$0.0B	$-0.0B	$-0.0B	$0.0B	-66.0	42
2019	$0.0B	$-0.0B	$-0.0B	$0.0B	-44.0	101
2020	$0.0B	$-0.0B	$-0.0B	$0.4B	-52.1	44
2022	$0.1B	$-0.0B	$-0.0B	$0.6B	-38.1	73
2023	$0.2B	$-0.0B	$-0.3B	$0.4B	-8.0	126
2024	$0.2B	$-0.0B	$-0.0B	$0.6B	-13.4	73
2025	$0.2B	$-0.1B	$-0.1B	$0.6B	-59.6	54